Rheumatology Doctors in Berkeley Heights, NJ Accepting Medicare

6 Rheumatology doctors found. Showing 1 - 6

Dr. Maria Gabriela Chancay, M.D. Internal Medicine - Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 1 Diamond Hill Rd, Berkeley Heights, NJ 07922 Phone: 908-273-4300

Dr. Linda K Lee, MD Internal Medicine - Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 1 Diamond Hill Rd, Summit Medical Group, Berkeley Heights, NJ 07922 Phone: 908-273-4300    Fax: 908-673-7241

Dr. Eric S Lieberman, MD Internal Medicine - Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 1 Diamond Hill Rd, Summit Medical Group, Berkeley Heights, NJ 07922 Phone: 908-273-4300    Fax: 908-673-7241

Ms. Swosty Tuladhar, M.D. Internal Medicine - Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 1 Diamond Hill Road, Bensley Pavilion, 3rd Floor, Berkeley Heights, NJ 07922 Phone: 908-277-8640

Dr. Lauren M. Kennish, MD Internal Medicine - Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 1 Diamond Hill Rd, Berkeley Heights, NJ 07922 Phone: 908-273-4300

Janaki Pinakin Patel, MD Internal Medicine - Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 1 Diamond Hill Rd, Berkeley Heights, NJ 07922 Phone: 908-277-8640    Fax: 908-673-7241

News Archive

BMJ investigation raises concern on rosiglitazone diabetes drug safety

A BMJ investigation into the top-selling diabetes drug rosiglitazone (Avandia) raises concerns about its safety and the whole system by which drugs are evaluated, regulated, and promoted around the world.

Researchers find new evidence to support structure-based classification system for viruses

Professor Robert Sinclair at the Okinawa Institute of Science and Technology Graduate University and Professor Dennis Bamford and Dr. Janne Ravantti from the University of Helsinki have found new evidence to support a classification system for viruses based on viral structure.

Survey investigates provider-beneficiary ratio in Medicaid managed care plans

Medicaid managed-care plans reported an average ratio of one primary-care provider for every 584 beneficiaries, according to a recent survey. The newly released results of a February survey from the member plans of the Association for Community Affiliated Plans reported that among the 25 responding health plans the ratio ranged from one primary-care provider for every 53 plan enrollees to 1 provider for each 2,000 patients.

New colon cancer target

New research led by scientists at the University of North Carolina at Chapel Hill School of Medicine have found a drug target that suggests a potent way to kill colon cancers that resist current drugs aimed at blocking a molecule found on the surface of cells.

ThromboGenics and BioInvent International present phase I results of novel anti-cancer monoclonal antibody

ThromboGenics NV and BioInvent International AB today announced positive results from a Phase I trial of their novel anti-cancer monoclonal antibody TB-403 in patients with advanced solid tumours. The results were presented at the AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics in Boston, U.S. TB-403 was well tolerated with no reported dose limiting toxicity. These positive data support progression of TB-403 and further development.

Read more Medical News

› Verified 8 days ago